Literature DB >> 16304171

Vancomycin-resistant Enterococcus faecium: catheter colonization, esp gene, and decreased susceptibility to antibiotics in biofilm.

Issam I Raad1, Hend A Hanna, Maha Boktour, Gassan Chaiban, Ray Y Hachem, Tanya Dvorak, Russell Lewis, Barbara E Murray.   

Abstract

To evaluate the molecular characteristics and antibiotic susceptibility in biofilm of vancomycin-resistant Enterococcus faecium (VREF) organisms that had caused catheter-related VREF bacteremia (VREF-CRB), we compared 22 isolates causing bacteremia obtained from patients with VREF-CRB with 30 isolates from control patients with gastrointestinal colonization by VREF. Using pulsed-field gel electrophoresis, we identified 17 unique strains among the 22 VREF-CRB isolates and 23 strains among the gastrointestinal isolates. The esp gene was detected in 53% (9 of 17) of the VREF-CRB and 61% (14 of 23) of the control strains (P = 0.6). VREF-CRB produced heavier biofilm colonization of silicone disks than did control organisms (P < 0.001). Daptomycin, minocycline, and quinupristin-dalfopristin were each independently more active than linezolid in reducing biofilm colonization by VREF-CRB (P < 0.01), with daptomycin being the most active, followed by minocycline. In conclusion, the esp gene in VREF is not associated with heavy biofilm colonization or catheter-related bacteremia. In biofilm, daptomycin and minocycline were the most active antibiotics against VREF, and linezolid was the least active.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16304171      PMCID: PMC1315928          DOI: 10.1128/AAC.49.12.5046-5050.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  45 in total

1.  In situ measurement of linezolid and vancomycin concentrations in intravascular catheter-associated biofilm.

Authors:  M H Wilcox; P Kite; K Mills; S Sugden
Journal:  J Antimicrob Chemother       Date:  2001-02       Impact factor: 5.790

Review 2.  Guidelines for the management of intravascular catheter-related infections.

Authors:  L A Mermel; B M Farr; R J Sherertz; I I Raad; N O'Grady; J S Harris; D E Craven
Journal:  Clin Infect Dis       Date:  2001-04-03       Impact factor: 9.079

3.  Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals.

Authors:  S K Fridkin; C D Steward; J R Edwards; E R Pryor; J E McGowan; L K Archibald; R P Gaynes; F C Tenover
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

4.  Daptomycin for line-related Leuconostoc bacteraemia.

Authors:  Y Golan; D D Poutsiaka; S Tozzi; S Hadley; D R Snydman
Journal:  J Antimicrob Chemother       Date:  2001-03       Impact factor: 5.790

Review 5.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

6.  Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro.

Authors:  B Amorena; E Gracia; M Monzón; J Leiva; C Oteiza; M Pérez; J L Alabart; J Hernández-Yago
Journal:  J Antimicrob Chemother       Date:  1999-07       Impact factor: 5.790

7.  Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation.

Authors:  K A Newell; J M Millis; P M Arnow; D S Bruce; E S Woodle; D C Cronin; G E Loss; H Grewal; T Lissoos; T Schiano; J Mead; J R Thistlethwaite
Journal:  Transplantation       Date:  1998-02-15       Impact factor: 4.939

8.  A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access.

Authors:  Anthony J Bleyer; Lori Mason; Gregory Russell; Issam I Raad; Robert J Sherertz
Journal:  Infect Control Hosp Epidemiol       Date:  2005-06       Impact factor: 3.254

9.  Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals.

Authors:  R J Willems; W Homan; J Top; M van Santen-Verheuvel; D Tribe; X Manzioros; C Gaillard; C M Vandenbroucke-Grauls; E M Mascini; E van Kregten; J D van Embden; M J Bonten
Journal:  Lancet       Date:  2001-03-17       Impact factor: 79.321

10.  vanA and vanB incorporate into an endemic ampicillin-resistant vancomycin-sensitive Enterococcus faecium strain: effect on interpretation of clonality.

Authors:  J P Suppola; E Kolho; S Salmenlinna; E Tarkka; J Vuopio-Varkila; M Vaara
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

View more
  13 in total

1.  Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents.

Authors:  J A McKinnell; M Patel; R M Shirley; D F Kunz; S A Moser; J W Baddley
Journal:  Epidemiol Infect       Date:  2010-11-15       Impact factor: 2.451

2.  Growth condition-dependent Esp expression by Enterococcus faecium affects initial adherence and biofilm formation.

Authors:  Willem J B Van Wamel; Antoni P A Hendrickx; Marc J M Bonten; Janetta Top; George Posthuma; Rob J L Willems
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

Review 3.  Daptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococci.

Authors:  Jose M Munita; Barbara E Murray; Cesar A Arias
Journal:  Int J Antimicrob Agents       Date:  2014-09-02       Impact factor: 5.283

4.  Enterococcal surface protein Esp is important for biofilm formation of Enterococcus faecium E1162.

Authors:  Esther Heikens; Marc J M Bonten; Rob J L Willems
Journal:  J Bacteriol       Date:  2007-09-07       Impact factor: 3.490

Review 5.  A potential role for daptomycin in enterococcal infections: what is the evidence?

Authors:  Rafael Cantón; Patricia Ruiz-Garbajosa; Ricardo L Chaves; Alan P Johnson
Journal:  J Antimicrob Chemother       Date:  2010-04-02       Impact factor: 5.790

6.  Catheter removal versus retention in the management of catheter-associated enterococcal bloodstream infections.

Authors:  Jonas Marschall; Marilyn L Piccirillo; Victoria J Fraser; Joshua A Doherty; David K Warren
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

7.  Successful Salvage of Central Venous Catheters in Patients with Catheter-Related or Central Line-Associated Bloodstream Infections by Using a Catheter Lock Solution Consisting of Minocycline, EDTA, and 25% Ethanol.

Authors:  Issam Raad; Anne-Marie Chaftari; Ramia Zakhour; Mary Jordan; Zanaib Al Hamal; Ying Jiang; Ammar Yousif; Kumait Garoge; Victor Mulanovich; George M Viola; Soha Kanj; Egbert Pravinkumar; Joel Rosenblatt; Ray Hachem
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

8.  Contribution of autolysin and Sortase a during Enterococcus faecalis DNA-dependent biofilm development.

Authors:  Pascale S Guiton; Chia S Hung; Kimberly A Kline; Robyn Roth; Andrew L Kau; Ericka Hayes; John Heuser; Karen W Dodson; Michael G Caparon; Scott J Hultgren
Journal:  Infect Immun       Date:  2009-06-15       Impact factor: 3.441

Review 9.  Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia.

Authors:  Philip I Hair; Susan J Keam
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  Biofilm formation, gel and esp gene carriage among recreational beach Enterococci.

Authors:  Ahmad Asmat; Ayokunle Christopher Dada; Usup Gires
Journal:  Glob J Health Sci       Date:  2014-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.